Literature DB >> 9130253

Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors.

M Carli1, S Afkhami-Dastjerdian, T A Reader.   

Abstract

The objectives of this study were to characterize the effects of a chronic lithium (Li+) treatment on serotonin (5-HT) uptake sites and on 5-HT1A receptors, and to determine the eventual reversibility of the treatment. The experiments were carried out with membranes from rat cerebral cortex using 8-hydroxy-2-(propylamino)tetralin, or [3H]8-OH-DPAT, and [3H]citalopram to label 5-HT1A receptors and 5-HT uptake sites, respectively. Endogenous levels of 5-HT and 5-hydroxyindole-3-acetic acid (5-HIAA) were measured by high-performance liquid chromatography in the cingulate cortex. The saturation curves with [3H]8-OH-DPAT were always best fitted a two-site model. After a treatment with Li+ for 28 days, no alterations in the binding parameters of [3H]8-OH-DPAT to the high- and low-affinity binding sites could be documented. However, competition curves with 5-HT to inhibit [3H]8-OH-DPAT binding revealed a decreased proportion of sites with high affinity for the agonist, together with an increased density of sites with low affinity for 5-HT, suggesting an alteration in the coupling efficacy between 5-HT1A receptors and their transduction systems. Saturation studies with [3H]citalopram showed an increase (> 40%) in the density of 5-HT uptake sites after chronic Li+, suggesting a more efficient 5-HT uptake process for the treated animals, in accord with clinical observations. Although 5-HT contents in cingulate cortex remained unchanged after the treatment, 5-H[AA levels decreased (> 30%), leading to a diminished (almost 50%) 5-HT turnover; and also reflecting a more efficient uptake in the treated rats, so that less 5-HT could be degraded by extracellular monoamine oxidase. All the effects revealed by [3H]8-OH-DPAT and [3H]citalopram were reversed following a recovery period of two days without Li+. Since symptoms of bipolar affective disorders may reappear if the chronic Li+ treatment is interrupted, the reversibility of the observed effects further supports the importance of central 5-HT synaptic transmission in the pathophysiology and treatment of human affective disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130253     DOI: 10.1023/a:1027355626355

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

1.  Autoradiography of serotonin receptor subtypes in the central nervous system.

Authors:  F Radja; A M Laporte; G Daval; D Vergé; H Gozlan; M Hamon
Journal:  Neurochem Int       Date:  1991       Impact factor: 3.921

2.  Multiple reactive sulfhydryl groups modulate the function of adenylate cyclase coupled beta-adrenergic receptors.

Authors:  J M Stadel; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

Review 3.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

4.  Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.

Authors:  E K Nénonéné; F Radja; M Carli; L Grondin; T A Reader
Journal:  J Neurochem       Date:  1994-05       Impact factor: 5.372

5.  5-HT uptake in platelets of lithium-treated patients with affective disorders and of healthy controls.

Authors:  K Thies-Flechtner; I Weigel; B Müller-Oerlinghausen
Journal:  Pharmacopsychiatry       Date:  1994-07       Impact factor: 5.788

6.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

7.  [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.

Authors:  M Carli; S Afkhami-Dastjerdian; T A Reader
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

8.  Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

Authors:  C de Montigny; G Cournoyer; R Morissette; R Langlois; G Caillé
Journal:  Arch Gen Psychiatry       Date:  1983-12

9.  Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets.

Authors:  G V Born; G Grignani; K Martin
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

10.  Change of synaptic membrane lipid composition and fluidity by chronic administration of lithium.

Authors:  B López-Corcuera; C Giménez; C Aragón
Journal:  Biochim Biophys Acta       Date:  1988-04-22
View more
  3 in total

1.  Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

2.  Differential effects of antidepressants escitalopram versus lithium on Gs alpha membrane relocalization.

Authors:  Robert J Donati; Jeffrey Schappi; Andrew H Czysz; Alexander Jackson; Mark M Rasenick
Journal:  BMC Neurosci       Date:  2015-07-11       Impact factor: 3.288

3.  Prediction of lithium treatment response in bipolar depression using 5-HTT and 5-HT1A PET.

Authors:  Mala Ananth; Elizabeth A Bartlett; Christine DeLorenzo; Xuejing Lin; Laura Kunkel; Nehal P Vadhan; Greg Perlman; Michala Godstrey; Daniel Holzmacher; R Todd Ogden; Ramin V Parsey; Chuan Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-13       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.